Prospective Randomized Study to Compare Results of Pelvic Organ Prolapse Repair With One Versus Two Vaginal Meshes

Sponsor
Ziv Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT02536001
Collaborator
(none)
100
2
34

Study Details

Study Description

Brief Summary

The purpose of this study is to compare anatomical differences, quality of life and sexual function and complications rate between apical support with one anterior vaginal mesh versus repair with two separate meshes.

Condition or Disease Intervention/Treatment Phase
  • Device: One mesh Endofast reliant system
  • Device: two meshes Endofast reliant system
N/A

Detailed Description

In the presence of stage 3 anterior wall prolapse (cystocele) with second stage apical prolapse (uterine or vault prolapse) there are 2 optional ways to repair with vaginal mesh: (a) to use 2 separated meshes: anterior mesh to correct the anterior compartment and posterior mesh to correct the apical prolapse to the sacrospinous ligament (SSL). (b) To correct both anterior compartment and the apical prolapse with the same mesh while using the posterior arms of the mesh to fix the apical prolapse to the SSL. Each way has its advantages and disadvantages. The first way was described at the beginning of mesh use and might be more anatomical then the second newest way. The addition of apical support to the anterior mesh might theoretically shorten the vagina. There are several recent studies describing the anatomical outcomes both for anterior compartment and apical compartment with a single mesh. Mesh-related complications, which can be also related to the amount of vaginal meshes, can potentially decrease with one mesh as compare with 2 meshes.

The aim of the study:

If the anatomical results, vaginal length and quality of life, will be with no significant differences between the two groups, the investigators will recommend to use a single mesh, in order to avoid / minimize potential complications of vaginal mesh.

If there will be no differences in complications in both groups but will be a significant difference in vaginal length and sexual function, the investigators will recommend using two meshes.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Prospective Randomized Study to Compare Anatomical, Functional and Sexual Results of Pelvic Organ Prolapse Repair With One Versus Two Vaginal Meshes While Preserving the Uterus
Study Start Date :
Sep 1, 2015
Anticipated Primary Completion Date :
Jul 1, 2017
Anticipated Study Completion Date :
Jul 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Other: One mesh Endofast reliant system

Patients with anterior compartment stage III and uterus prolapse grade II will be treated with one mesh - Anterior Endofast reliant system (fixation of posterior arms to the sacrospinous ligament)

Device: One mesh Endofast reliant system
One mesh (anterior One mesh Endofast reliant system) will be used to correct both anterior and apical prolapse

Other: two meshes Endofast reliant system

intervention: Patients with anterior compartment stage III and uterus prolapse grade II will be treated with 2 meshes: anterior Endofast reliant system mesh to correct the anterior compartment and posterior Endofast reliant system mesh to correct the apical prolapse (fixation to the sacrospinous ligament)

Device: two meshes Endofast reliant system
Two meshes (anterior and posterior Endofast reliant system) will be used to correct separately the anterior compartment and the apical compartment

Outcome Measures

Primary Outcome Measures

  1. Vaginal length between the arms [2 years]

    measure total vaginal length after surgery

  2. Quality of life [2 years]

    use validated questionnaires before and after surgery

  3. Complications rate [2 years]

    comparing complications rate between groups

  4. Sexual function [2 years]

    use validated questionnaires before and after surgery

Secondary Outcome Measures

  1. To examine anatomical results [2 years]

    use POP-Q and compare between the groups

  2. Success rate of uterus preservation [2 years]

    success will be define as no bulge symptoms and <stage II

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 85 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • At least anterior compartment prolapse stage III and uterine prolapse stage II.
Exclusion Criteria:
  • Women without uterine prolapse, or with uterine prolapse < stage 2.

  • Women with uterine prolapse > stage 2.

  • Hysterectomy in the past.

  • Women with an indication for hysterectomy.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Ziv Hospital

Investigators

  • Study Chair: Naama Marcus Braun, MD, Ziv Medical center, Israel

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ziv Hospital
ClinicalTrials.gov Identifier:
NCT02536001
Other Study ID Numbers:
  • 0032-15-ZIV
First Posted:
Aug 31, 2015
Last Update Posted:
Aug 31, 2015
Last Verified:
May 1, 2015
Keywords provided by Ziv Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 31, 2015